HSBC noted that while the market has assumed a significant market share for Eli Lilly, these expectations may be revised in light of potential economic sensitivity to the adoption curve for weight loss drugs.
The $150 billion investment will include more than $30 billion in research and development to advance and continue IBM's American manufacturing of mainframe and quantum computers.
Technology and consulting giant IBM (NYSE:IBM) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $14.54 billion. The company expects next quarter’s revenue to be around $16.56 billion, close to analysts’ estimates. Its non-GAAP profit of $1.60 per share was 12% above analysts’ consensus estimates.
Sen. Elizabeth Warren requests answers from Apple Inc. CEO Tim Cook over alleged influence-peddling between Apple and Trump administration in trade negotiations with China. Tech companies release mixed earnings results.
IBM's stock fell 6% in today’s trading session despite beating its first-quarter expectations after-market hours on Wednesday and maintaining its full-year revenue guidance.
Shares of technology and consulting giant IBM (NYSE:IBM) fell 7.5% in the afternoon session after the company reported mixed first-quarter 2025 results, as a significant operating income miss weighed on the overall performance. On the other hand, IBM exceeded expectations for revenue, adjusted EPS, and EBITDA. Overall, we think this was a decent quarter, with some key metrics above expectations. The areas below expectations seem to be driving the move, and shares traded down.
